The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD

Respiratory Medicine

Volumn 146, Issue , 2019, Pages 87-95

  Reijnders, Thomas ^a   Schuler, Michael ^b   Wittmann, Michael ^c   Jelusic, Danijel ^c   Troosters, Thierry ^a   Janssens, Wim ^a   Stenzel, Nikola M ^d   Schultz, Konrad ^c   von Leupoldt, Andreas ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Bad Reichenhall Clinic   (Germany)

^d Psychologische Hochschule   (Germany)

Author keywords

Anxiety; COPD; Disease specific fears; Functional capacity; Pulmonary rehabilitation; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DISEASE EXACERBATION; DISEASE SPECIFIC FEAR; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; SIX MINUTE WALK TEST; SOCIAL EXCLUSION; AGED; CROSS-SECTIONAL STUDY; FEAR; PROSPECTIVE STUDY; PSYCHOLOGY; TREATMENT OUTCOME;

AGED; ANXIETY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DYSPNEA; FEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 85058616945     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2018.12.004     Document Type: Article

References (68)

1. G.I. for C.O.L.D. (GOLD), From the Global Strategy for the Diagnosis, Management and Prevention of COPD. 2017 http://goldcopd.org.
2. Troosters, T., Gosselink, R., Decramer, M., Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am. J. Med. 109 (2000), 207–212 http://www.ncbi.nlm.nih.gov/pubmed/10974183.
3. Spruit, M.A., Singh, S.J., Garvey, C., Zu Wallack, R., Nici, L., Rochester, C., et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Hill, A.E. Holland, S.C. Lareau, W.D.C. Man, F. Pitta, L. Sewell, J. Raskin Am. J. Respir. Crit. Care Med., 188, 2013, 10.1164/rccm.201309-1634ST.
4. McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., Lacasse, Y., Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., 2015, 1–209, 10.1002/14651858.CD003793.pub3 2015 www.cochranelibrary.com.
5. Vanfleteren, L.E.G.W., Spruit, M.A., Groenen, M., Gaffron, S., Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary Disease. Am. J. Respir. Crit. Care Med. 187 (2013), 728–735, 10.1164/rccm.201209-1665OC.
6. Willgoss, T.G., Yohannes, A.M., Anxiety disorders in patients with chronic obstructive pulmonary disease: a systematic review. Respir. Care 58 (2012), 858–866, 10.4187/respcare.01862.
7. von Leupoldt, A., Kenn, K., The psychology of chronic obstructive pulmonary disease. Curr. Opin. Psychiatr. 26 (2013), 458–463, 10.1097/YCO.0b013e328363c1fc.
8. Atlantis, E., Fahey, P., Cochrane, B., Smith, S., Bidirectional associations between clinical1. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 144 (2013), 766–777, 10.1378/chest.12-1911 [Internet]. The American College of, Chest.
9. Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M.E., Yohannes, A.M., et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 134 (2008), 43–56, 10.1378/chest.08-0342.
10. Yohannes, A.M., Alexopoulos, G.S., Depression and anxiety in patients with COPD. Eur. Respir. Rev. 23 (2014), 345–349, 10.1183/09059180.00007813.
11. Janssens, T., De Peuter, S., Stans, L., Verleden, G., Troosters, T., Decramer, M., et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 140 (2011), 618–625, 10.1378/chest.10-3257.
12. von Leupoldt, A., Janssens, T., Could targeting disease specific fear and anxiety improve COPD outcomes?. Expert Rev. Respir. Med. 6348 (2016), 835–837, 10.1080/17476348.2016.1198697.
13. Irvine, E.J., Review article: patients’ fears and unmet needs in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20:Suppl 4 (2004), 54–59, 10.1111/j.1365-2036.2004.02053.x.
14. Bellizzi, K.M., Latini, D.M., Cowan, J.E., DuChane, J., Carroll, P.R., Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology 72 (2008), 1269–1273, 10.1016/j.urology.2007.12.084.
15. Myers, S.B., Manne, S.L., Kissane, D.W., Ozga, M., Kashy, D.A., Rubin, S., et al. Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers. Gynecol. Oncol. 128 (2013), 120–127, 10.1016/j.ygyno.2012.10.014.
16. Åsenlöf, P., Söderlund, A., A further investigation of the importance of pain cognition and behaviour in pain rehabilitation: longitudinal data suggest disability and fear of movement are most important. Clin. Rehabil. 24 (2010), 422–430, 10.1177/0269215509353264.
17. Zoeckler, N., Kenn, K., Kuehl, K., Stenzel, N., Rief, W., Illness perceptions predict exercise capacity and psychological well-being after pulmonary rehabilitation in COPD patients. J. Psychosom. Res. 76 (2014), 146–151, 10.1016/j.jpsychores.2013.11.021.
18. Fischer, M.J., Scharloo, M., Abbink, J., Van ’T Hul, A., Van Ranst, D., Rudolphus, A., et al. Concerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD. Int. J. Behav. Med. 19 (2012), 39–47, 10.1007/s12529-010-9130-9.
19. Solomon, B.K., Wilson, K.G., Henderson, P.R., a Poulin, P., Kowal, J., a McKim, D., A Breathlessness Catastrophizing Scale for chronic obstructive pulmonary disease. J. Psychosom. Res., 2014, 10.1016/j.jpsychores.2014.11.020.
20. Keil, D.C., Stenzel, N.M., Kühl, K., Vaske, I., Mewes, R., Rief, W., Kenn, K., The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability_CAFR. Chron. Respir. Dis. 11 (2014), 31–40, 10.1177/1479972313516881.
21. K. Schultz, D. Jelusic, M. Wittmann, B. Krämer, V. Huber, S. Fuchs, et al., Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial, Eur. Respir. J. Inspiratory. (n.d.).
22. Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. Standardisation of spirometry. Eur. Respir. J. 26 (2005), 319–338, 10.1183/09031936.05.00034805.
23. ATS Statement, Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 166 (2002), 111–117.
24. Ware, J., Sherbourne, C., The MOS 36-item short-form health Survey (SF-36). I. Conceptual Framework and Item Selection Author (s): John E. Ware, Jr. and Cathy Donald Sherbourne Published by: Lippincott Williams & Wilkins Stable Med. Care 30 (1992), 473–483 http://www.jstor.org/stable/3765916 Ac.
25. Alonso, J., Prieto, L., Vilagut, G., Broquetas, J.M., Roca, J., Batlle, J.S., Testing the measurement properties of the Spanish version of the SF-36 health Survey among male patients with chronic obstructive. Pulmonary Disease 51 (1998), 1087–1094.
26. Kroenke, K., Spitzer, R.L., Williams, J.B.W., The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16 (2001), 606–613, 10.1046/j.1525-1497.2001.016009606.x.
27. Spitzer, R.L., Kroenke, K., Williams, J.B.W., Löwe, B., A brief measure for assessing generalized anxiety disorder. Arch. Intern. Med. 166 (2006), 1092–1097, 10.1001/archinte.166.10.1092.
28. Schuler, M., Strohmayer, M., Mühlig, S., Schwaighofer, B., Wittmann, M., Faller, H., et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J. Affect. Disord. 232 (2018), 268–275, 10.1016/j.jad.2018.02.037.
29. Jones, P.W., Harding, G., Berry, P., Wiklund, I., Chen, W.H., Kline Leidy, N., Development and first validation of the COPD assessment test. Eur. Respir. J. 34 (2009), 648–654, 10.1183/09031936.00102509.
30. Jones, P.W., Harding, G., Wiklund, I., Berry, P., Tabberer, M., Yu, R., et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 142 (2012), 134–140, 10.1378/chest.11-0309.
31. N.I.C. IBM Corp Released 2016, IBM SPSS Statistics for Macintosh. 2005, IBM Corp. Version 24.0. Armonk.
32. Coventry, P.A., Hind, D., Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J. Psychosom. Res. 63 (2007), 551–565, 10.1016/j.jpsychores.2007.08.002.
33. Griffiths, T.L., Burr, M.L., Campbell, I.A., Mullins, J., Shiels, K., Payne, N., et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation : a randomised controlled trial. Lancet 355 (2000), 362–368.
34. Guell, R., Resqueti, V., Sangenis, M., Morante, F., Martorell, B., Casan, P., et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest, 129, 2006, 899, 10.1378/chest.129.4.899.
35. Ries, A.L., Bauldoff, G.S., Carlin, B.W., Casaburi, R., Emery, C.F., Mahler, D.A., et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest, 131, 2007, 10.1378/chest.06-2418 4S–42S.
36. Puhan, M.A., Gimeno- Santos, E., Cates, C.J., T. T, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (Review). Cochrane Database Syst. Rev., 2016, 10.1002/14651858.CD005305.pub4 www.cochranelibrary.com.
37. von Leupoldt, A., Dahme, B., Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir. Med. 101 (2007), 411–422, 10.1016/j.rmed.2006.06.011.
38. Seamark, D.A., Blake, S.D., Seamark, C.J., Halpin, D.M., Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. Palliat. Med. 18 (2004), 619–625, 10.1191/0269216304pm928oa.
39. Hu, J., Meek, P., Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart & Lung J. Acute Crit. Care 34 (2005), 415–422, 10.1016/j.hrtlng.2005.03.008.
40. Spathis, A., Booth, S., Moffat, C., Hurst, R., Ryan, R., Chin, C., et al. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. Npj Prim. Care Respir. Med. 27 (2017), 1–5, 10.1038/s41533-017-0024-z.
41. Thomas, M., Decramer, M., O'Donnell, D.E., No room to breathe: the importance of lung hyperinflation in COPD. Prim. Care Respir. J. 22 (2013), 101–111, 10.4104/pcrj.2013.00025.
42. Smoller, J.W., Pollack, M.H., Otto, M.W., Rosenbaum, J.F., Kradin, R.L., Panic anxiety, dyspnea, and respiratory disease: theoretical and clinical considerations. Am. J. Respir. Crit. Care Med. 154 (1996), 6–17, 10.1164/ajrccm.154.1.8680700.
43. Carrieri-Kohlman, V., Douglas, M.K., Gormley, J.M., Stulbarg, M.S., Desensitization and guided mastery - treatment approaches for the management of dyspnea. Heart Lung 22 (1993), 226–234.
44. Livermore, N., Dimitri, A., Sharpe, L., McKenzie, D.K., Gandevia, S.C., Butler, J.E., Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir. Physiol. Neurobiol., 216, 2015, 10.1016/j.resp.2015.05.013.
45. Eloffson, L.C., Öhlén, J., Elofsson, L.C., Ohlen, J., Meanings of being old and living with chronic obstructive pulmonary disease. Palliat. Med. 18 (2004), 611–618, 10.1191/0269216304pm922oa.
46. Barnett, M., Chronic obstructive pulmonary disease: a phenomenological study of patients’ experiences. J. Clin. Nurs. 14 (2005), 805–812, 10.1111/j.1365-2702.2005.01125.x.
47. Hutchinson, A., Barclay-Klingle, N., Galvin, K., Johnson, M.J., Living with breathlessness: a systematic literature review and qualitative synthesis. Eur. Respir. J., 51, 2018, 1701477, 10.1183/13993003.01477-2017.
48. Herschbach, P., Book, K., Dinkel, A., Berg, P., Waadt, S., Duran, G., et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support. Care Canc. 18 (2010), 471–479, 10.1007/s00520-009-0696-1.
49. Stenzel, N.M., Vaske, I., Kühl, K., Kenn, K., Rief, W., Prediction of end-of-life fears in COPD – hoping for the best but preparing for the worst. Psychol. Health 30 (2015), 1017–1034, 10.1080/08870446.2015.1014816.
50. Stenzel, N., Rief, W., Kühl, K., Pinzer, S., Kenn, K., Progredienzangst und End-of-Life-Ängste bei COPD-Patienten. Pneumologie 66 (2012), 111–118, 10.1055/s-0031-1291637.
51. Woby, S.R., Watson, P.J., Roach, N.K., Urmston, M., Are changes in fear-avoidance beliefs, catastrophizing, and appraisals of control, predictive of changes in chronic low back pain and disability?. Eur. J. Pain 8 (2004), 201–210, 10.1016/j.ejpain.2003.08.002.
52. Koho, P., Orenius, T., Kautiainen, H., Haanp, M., Pohjolainen, T., Hurri, H., Association of fear of movement and leisure-time physical activity among patients with chronic pain. J. Rehabil. Med. 43 (2011), 794–799, 10.2340/16501977-0850.
53. Von Leupoldt, A., Treating anxious expectations can improve dyspnoea in patients with COPD. Eur. Respir. J., 50, 2017, 10.1183/13993003.01352-2017.
54. Benzo, R.P., Abascal-Bolado, B., Dulohery, M.M., Self-management and quality of life in chronic obstructive pulmonary disease (COPD): the mediating effects of positive affect. Patient Educ. Counsel. 99 (2016), 617–623, 10.1016/j.pec.2015.10.031.
55. Davis, A.H.T., Carrieri-Kohlman, V., Janson, S.L., Gold, W.M., Stulbarg, M.S., Effects of treatment on two types of self-efficacy in people with chronic obstructive pulmonary disease. J. Pain Symptom Manag. 32 (2006), 60–70, 10.1016/j.jpainsymman.2006.01.012.
56. Bentsen, S.B., Wentzel-Larsen, T., Henriksen, A.H., Rokne, B., Wahl, A.K., Self-efficacy as a predictor of improvement in health status and overall quality of life in pulmonary rehabilitation-An exploratory study. Patient Educ. Counsel. 81 (2010), 5–13, 10.1016/j.pec.2009.11.019.
57. Bailey, P.H., The dyspnea-anxiety-dyspnea cycle - COPD patients’ stories of breathlessness: “It's scary/when you can't breathe. Qual. Health Res. 14 (2004), 760–778, 10.1177/1049732304265973.
58. Leeuw, M., Goossens, M.E.J.B., van Breukelen, G.J.P., de Jong, J.R., Heuts, P.H.T.G., Smeets, R.J.E.M., et al. Exposure in vivo versus operant graded activity in chronic low back pain patients: results of a randomized controlled trial. Pain 138 (2008), 192–207, 10.1016/j.pain.2007.12.009.
59. Vlaeyen, J.W.S., de Jong, J., Geilen, M., Heuts, P.H.T.G., van Breukelen, G., The treatment of fear of movement/(Re)injury in chronic low back pain: further evidence on the effectiveness of exposure in vivo. Clin. J. Pain 18 (2002), 251–261, 10.1097/00002508-200207000-00006.
60. Macedo, L.G., Smeets, R.J.E.M., Maher, C.G., Latimer, J., McAuley, J.H., Graded activity and graded exposure for persistent nonspecific low back pain: a systematic review. Phys. Ther. 90 (2010), 860–879, 10.2522/ptj.20090303.
61. Halding, A.-G., Wahl, A., Heggdal, K., ‘Belonging’. ‘Patients’’ experiences of social relationships during pulmonary rehabilitation. Disabil. Rehabil. 32 (2010), 1272–1280, 10.3109/09638280903464471.
62. Monninkhof, E., Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax 58 (2003), 394–398, 10.1136/thorax.58.5.394.
63. Geidl, W., Semrau, J., Streber, R., Lehbert, N., Wingart, S., Tallner, A., et al. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial. Trials 18 (2017), 1–10, 10.1186/s13063-017-2124-z.
64. Pitta, F., Troosters, T., Probst, V.S., Spruit, M.A., Decramer, M., Gosselink, R., Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur. Respir. J. 27 (2006), 1040–1055, 10.1183/09031936.06.00064105.
65. Puhan, M.A., Chandra, D., Mosenifar, Z., Ries, A., Make, B., Hansel, N.N., Wise, R.A., Sciurba, F., The minimal important difference of exercise tests in severe COPD. Eur. Respir. J. 37 (2011), 784–790, 10.1183/09031936.00063810.
66. Swigris, J.J., Brown, K.K., Behr, J., du Bois, R.M., King, T.E., Raghu, G., Wamboldt, F.S., The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir. Med. 104 (2010), 296–304, 10.1016/j.rmed.2009.09.006.
67. Lüwe, B., Unützer, J., Callahan, C.M., Perkins, A.J., Kroenke, K., Monitoring depression treatment outcomes with the patient health questionnaire-9. Med. Care 42 (2004), 1194–1201, 10.1097/00005650-200412000-00006.
68. Kocks, J.W.H., Tuinenga, M.G., Uil, S.M., van den Berg, J.W.K., Ståhl, E., van der Molen, T., Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir. Res., 7, 2006, 1, 10.1186/1465-9921-7-62.